Brightstar: Announces two new investments, releases 2017 annual report
|BrightStar announces two new investments, releases 2017 annual report
MILWAUKEE, March 29, 2018 – BrightStar Wisconsin Foundation Inc. today announced that it has committed $100,000 to Cytometix Inc., d.b.a. Cmxtwenty, and $50,000 to GenoPalate Inc. Both companies are based in the Milwaukee area and have ties to the Medical College of Wisconsin.
During the past decade, Cmxtwenty developed a therapeutic pharmaceutical that is modeled after the body’s natural pain-control chemistry. The result is a pain therapy that does not have the devastating effects of opioids and can be offered both orally and intravenously.
“Not only did BrightStar give us the capital essential to finishing our current clinical study, the foundation also assisted us with identifying prospective angel and other investors, which brought in substantially more capital as we take the next key steps towards commercialization of this powerful product in 2018,” said Lane Brodstrom, Cmxtwenty’s chief executive. For more information about Cmxtwenty and its non-narcotic pain treatment, go tohttp://cmxtwenty.com.
GenoPalate last year completed the gener8tor program and offers diet plans based on an analysis of an individual’s DNA. A customer sends a saliva sample to the company and, in return, is provided a customized report reflecting his or her nutritional needs, including unique tolerances to food or alcohols, supplement suggestions, and personalized shopping lists.
“After a decade of research on how our genetics influence our metabolic health, my talented team and I are excited about bringing our science and technology to people's daily lives for smart shopping and eating that can lead to their optimal health,” said Sherry Zhang, the company’s founder and chief executive. “We are recruiting, hiring, and training talent for our high-tech health startup and collaborating with Wisconsin-focused organizations like BrightStar will expedite this process.” For more information about GenoPalate and the GenoPalate lifestyle, go to www.genopalate.com.
BrightStar also announced that it has released its 2017 annual report, which summarizes the organization’s investment and support activities during 2017. The report also highlights BrightStar’s portfolio companies and its job-creation progress in Wisconsin. To see a digital version of the report, click the link that follows: BrightStar’s 2017 Annual Report. If you’d like to receive a printed copy of the annual report, send an email request email@example.com.
About the BrightStar Wisconsin Foundation Inc.
BrightStar is a 501(c)(3) non-profit foundation created to facilitate job creation and increase Wisconsin’s economic activity by deploying donated funds into equity stakes in early-stage, rapid growth companies. This new approach enables the formation of new investment capital in Wisconsin through charitable donations to the foundation. Contributions to BrightStar are tax deductible.